- $53.71m
- $16.07m
- $12.89m
- 24
- 29
- 32
- 17
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.1 | ||
| Price to Tang. Book | 1.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.17 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -86.15% | ||
| Return on Equity | -61.03% | ||
| Operating Margin | -335.33% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.29 | 1.5 | 6.81 | 11.03 | 12.89 | 15.67 | 20.17 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 21st, 2021
- Public Since
- January 27th, 2021
- No. of Shareholders
- 104
- No. of Employees
- 111
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Market- Shares in Issue
- 77,832,318
- Address
- 351 New Whitfield Street, GUILFORD, 06437
- Web
- https://hyperfine.io/
- Phone
- Contact
- Marissa Bych
- Auditors
- Grant Thornton LLP
Upcoming Events for HYPR
Q1 2025 Hyperfine Inc Earnings Call
Hyperfine Inc Annual Shareholders Meeting
Hyperfine Inc Annual Shareholders Meeting
Q2 2025 Hyperfine Inc Earnings Release
Similar to HYPR
908 Devices
NASDAQ Global Market
Alpha Teknova
NASDAQ Global Market
Anteris Technologies Global
NASDAQ Global Market
AtriCure
NASDAQ Global Market
Beta Bionics
NASDAQ Global Market
FAQ
What is the Hyperfine share price?
As of Today at 21:12 UTC, shares in Hyperfine are trading at $0.69. This share price information is delayed by 15 minutes.
How has the Hyperfine share price performed this year?
Shares in Hyperfine last closed at $0.69 and the price had moved by -12.97% over the past 365 days. In terms of relative price strength the Hyperfine share price has underperformed the S&P500 Index by -21.52% over the past year.
What are the analyst and broker recommendations for Hyperfine?
The overall consensus recommendation for Hyperfine is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Hyperfine dividend yield?
Hyperfine does not currently pay a dividend.
Does Hyperfine pay a dividend?
Hyperfine does not currently pay a dividend.
When does Hyperfine next pay dividends?
Hyperfine does not currently pay a dividend.
How do I buy Hyperfine shares?
To buy shares in Hyperfine you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hyperfine?
As of the previous close price of $0.69, shares in Hyperfine had a market capitalisation of $53.71m.
Where are Hyperfine shares listed?
Here are the trading details for Hyperfine:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: HYPR
What kind of share is Hyperfine?
Based on an overall assessment of its quality, value and momentum Hyperfine is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hyperfine share price forecast for 2025?
The analyst consensus target price for shares in Hyperfine is $1.30. That is 88.38% above the last closing price of $0.69.
Analysts covering Hyperfine currently have a consensus Earnings Per Share (EPS) forecast of -$0.45 for the next financial year.
Find out moreWhat is the trend in the Hyperfine share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hyperfine. Over the past six months, its share price has underperformed the S&P500 Index by -29.26%.
As of the last closing price of $0.69, shares in Hyperfine were trading -29.72% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hyperfine PE Ratio?
The Hyperfine PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hyperfine?
We do not have data on Hyperfine's directors